Fieldpoint Private Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $96K | Sell |
1,155
-3
| -0.3% | -$249 | 0.03% | 374 |
|
|
2022
Q1 | $89K | Buy |
+1,158
| New | +$89K | 0.02% | 453 |
|
|
2021
Q3 | – | Sell |
-1,627
| Closed | -$125K | – | 1644 |
|
|
2021
Q2 | $125K | Sell |
1,627
-268
| -14% | -$20.6K | 0.03% | 377 |
|
|
2021
Q1 | $143K | Sell |
1,895
-527
| -22% | -$39.8K | 0.03% | 339 |
|
|
2020
Q4 | $212K | Sell |
2,422
-369
| -13% | -$32.3K | 0.05% | 276 |
|
|
2020
Q3 | $212K | Buy |
2,791
+716
| +35% | +$54.4K | 0.06% | 259 |
|
|
2020
Q2 | $256K | Sell |
2,075
-2,885
| -58% | -$356K | 0.09% | 205 |
|
|
2020
Q1 | $419K | Buy |
4,960
+232
| +5% | +$19.6K | 0.16% | 147 |
|
|
2019
Q4 | $400K | Buy |
4,728
+1,435
| +44% | +$121K | 0.12% | 176 |
|
|
2019
Q3 | $222K | Buy |
3,293
+900
| +38% | +$60.7K | 0.08% | 204 |
|
|
2019
Q2 | $205K | Sell |
2,393
-305
| -11% | -$26.1K | 0.06% | 223 |
|
|
2019
Q1 | $240K | Sell |
2,698
-280
| -9% | -$24.9K | 0.1% | 181 |
|
|
2018
Q4 | $254K | Buy |
+2,978
| New | +$254K | 0.11% | 171 |
|